COVID-19 Disease and Coagulopathy: Assessment of Clotting Factor Levels in Patients With SARS-CoV-2 Infection

Completed

• Conditions: SARS-COV2 Infection; COVID-19 Disease; Hospitalized Patients

• Registration Number: NCT04787510
• Lead Sponsor: University Hospital, Ioannina

Brief Summary

Effect of Covid-19 disease in clotting factors levels in hospitalized patients

Detailed Description

Effect of Covid-19 disease in clotting factors levels in hospitalized patients positive for sars-cov2 infection.

Association between clotting factors levels and disease severity,morbidity and mortality in these patients.

Effect of anticoagulant therapy in the clotting factors' levels in these patients

Study Timeline

• Study Start: 2020-12-23
• Study First Submitted: 2021-03-04
• Study First Submitted QC: 2021-03-05
• Study First Posted: 2021-03-08
• Primary Completion: 2021-05-23
• Study Completion: 2021-06-23
• Status Verified: 2021-09
• Last Update Submitted: 2021-09-27
• Last Update Posted: 2021-09-28

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

• AGE> 18
• SINGED INFORMED CONSENT FORM
• POSITIVE PCR TEST FOR SARS-COV2 INFECTION
• FINDINGS IN CXR OR CT OF THE LUNGS CONSISTENT WITH INFECTION OF LOWER RESPIRATORY TRACT

Exclusion Criteria

• AGE<18
• DENIAL TO PROVIDE INFORMED CONSENT FORM
• HISTORY OF MALIGNANCY
• PRIOR USE OF ANTICOAGULANT THERAPY
• PRIOR USE OF STEROIDS LONGER THAN 14 DAYS
• LACTATION-PREGNANCY

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
EFFECT OF COVID-19 DISEASE IN CLOTTING FACTORS	6 MONTHS	leves of cloting factors before and after treatment with LMWH

Trial Locations

Locations (1)

University General Hospital of Ioannina; 🇬🇷 Ioánnina, Epirus, Greece